Published in Clin Exp Allergy on February 01, 2004
A Birth Cohort Study of Maternal and Infant Serum PCB-153 and DDE Concentrations and Responses to Infant Tuberculosis Vaccination. Environ Health Perspect (2015) 0.89
Preventive effects of mycobacteria and their culture supernatants against asthma development in BALB/c mice. Allergy Asthma Immunol Res (2009) 0.87
BCG-induced dendritic cell responses and suppression of interleukin-5 production from T cells in atopic asthmatics. J Korean Med Sci (2008) 0.82
Inoculation route-dependent and allergen-specific suppressive effects of bacille Calmette-Guérin vaccination on asthmatic reactions in BALB/c mice. Lung (2007) 0.82
Ag85B DNA vaccine suppresses airway inflammation in a murine model of asthma. Respir Res (2009) 0.81
Personal Factors Affecting Therapeutic Responses to BCG Vaccination in Asthmatics. Allergy Asthma Immunol Res (2011) 0.80
Therapeutic effects of mycobacterial secretory proteins against established asthma in BALB/c mice. Allergy Asthma Immunol Res (2012) 0.78
Primary prevention of allergic diseases: current concepts and mechanisms. Allergy Asthma Clin Immunol (2007) 0.75
Usefulness of mycobacteria in redirecting the immune response in atopic disease. Clin Exp Allergy (2004) 0.75
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Tranquillizers. Br Med J (1962) 3.75
Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34
Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30
Cannabis use and risk of lung cancer: a case-control study. Eur Respir J (2008) 3.29
Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ (1998) 3.15
How much asthma is really attributable to atopy? Thorax (1999) 3.04
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02
COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97
The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis (2005) 2.65
The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61
Personal factors as a cause of differences in prescribing by general practitioners. Br J Prev Soc Med (1968) 2.38
Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (2009) 2.37
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax (2010) 2.36
Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27
Analysis of symptoms of patients with headaches and their response to treatment with ergot derivatives. Q J Med (1968) 2.19
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Proportional classifications of COPD phenotypes. Thorax (2008) 2.10
Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06
Baseline risk for asthma deaths. N Z Med J (1992) 2.02
Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99
Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax (2005) 1.95
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87
The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79
Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart (2008) 1.78
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72
Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy (2011) 1.68
Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ (2001) 1.67
Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med (1996) 1.66
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child (2004) 1.62
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects. J Rheumatol (1988) 1.60
Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain (1999) 1.54
Mefenamic acid and flufenamic acid compared with aspirin and phenylbutazone in rheumatoid arthritis. Br Med J (1966) 1.52
Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. Eur Respir J (2004) 1.50
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
Is allergen exposure the major primary cause of asthma? Thorax (2000) 1.48
The effect of the increased prescription charges on the collection of asthma drugs. N Z Med J (1992) 1.48
A study of the management of asthma in a hospital emergency department. N Z Med J (1989) 1.47
Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions. J Allergy Clin Immunol (2001) 1.46
Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy (1999) 1.43
Use of a management plan for treating asthma in an emergency department. Thorax (1990) 1.40
Streptomycin and Promanide in Experimental Ocular Tuberculosis. Br J Ophthalmol (1950) 1.40
Fenoterol, asthma deaths, and asthma severity: confounding or confusion? Thorax (1997) 1.39
Fenoterol and asthma death. N Z Med J (1989) 1.39
Asthma deaths in New Zealand. BMJ (1992) 1.38
Fenoterol: confounding again. N Z Med J (1989) 1.38
Inappropriate use of inhaled beta agonists in asthma. N Z Med J (1990) 1.37
Prescribing for childhood asthma in the Wellington area: comparison with international guidelines. N Z Med J (1993) 1.37
The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma. Am Rev Respir Dis (1987) 1.33
Assessment of drugs in out-patients with rheumatoid arthritis. Evaluation of methods and a comparison of mefenamic and flufenamic acids with phenylbutazone and aspirin. Ann Rheum Dis (1967) 1.31
Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation. Br Med J (Clin Res Ed) (1985) 1.30
Measuring the prevalence of bronchial hyper-responsiveness in children. Int J Epidemiol (1995) 1.24
Comparison of a video questionnaire with the IUATLD written questionnaire for measuring asthma prevalence. Clin Exp Allergy (1992) 1.23
Relationship between fetal growth and the development of asthma and atopy in childhood. Thorax (1999) 1.23
The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation. Postgrad Med J (1990) 1.18
Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health (2001) 1.14
Agreement between written and video questions for comparing asthma symptoms in ISAAC. Eur Respir J (2003) 1.14
Reduced selenium status of patients with asthma. Clin Sci (Lond) (1989) 1.14
Role of bronchial responsiveness testing in asthma prevalence surveys. Thorax (2000) 1.12
Prevalence of asthma symptoms among adolescents in the Wellington region, by area and ethnicity. N Z Med J (1993) 1.10
Reduced selenium in asthmatic subjects in New Zealand. Thorax (1990) 1.09
The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma. Br J Clin Pharmacol (1988) 1.09
Genetic analysis of atopy and asthma as quantitative traits and ordered polychotomies. Ann Hum Genet (1994) 1.08
Association of beta2-adrenergic receptor polymorphisms with severe asthma. Clin Exp Allergy (2000) 1.07
Venous thromboembolism following prolonged cast immobilisation for injury to the tendo Achillis. J Bone Joint Surg Br (2010) 1.06
Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy (2008) 1.05
The magnitude of the effect of smaller family sizes on the increase in the prevalence of asthma and hay fever in the United Kingdom and New Zealand. J Allergy Clin Immunol (1999) 1.05
Humidified nasal continuous positive airway pressure in obstructive sleep apnoea. Eur Respir J (2003) 1.05
Seasonal variation in asthma hospitalizations and death rates in New Zealand. Respirology (2000) 1.04
Use of cluster analysis to define COPD phenotypes. Eur Respir J (2010) 1.02
The pathogenesis and significance of bronchial hyper-responsiveness in airways disease. Clin Sci (Lond) (1987) 1.02
The rise and rise of asthma: a new paradigm for the new millennium? J Epidemiol Biostat (2000) 1.00
Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis. Eur Respir J (2006) 1.00